Skip to main content
SpringerLink
Log in

Ectopic expression of Rsu-1 results in elevation of p21CIP and inhibits anchorage-independent growth of MCF7 breast cancer cells

  • Published:
Breast Cancer Research and Treatment Aims and scope Submit manuscript

Abstract

Signal transduction from tyrosine kinase receptors mediates growth regulation of breast cancer cells in part through the GTPase Ras and downstream kinases. Rsu-1 is a cDNA previously identified as an inhibitor of Ras-induced transformation. An HA-epitope tagged Rsu-1 cDNA was introduced into the MCF7 breast carcinoma cell line. Stable transfectants were selected and used for analysis of Rsu-1 expression on growth control and Ras-dependent kinase pathways. Assessment of biological activity of HA-Rsu-1 transfectants revealed that HA-Rsu-1 clones showed slower anchorage dependent growth rates than control MCF7 cell lines and a significant reduction in anchorage independent growth. Analysis of cell cycle regulatory proteins required for transit through G1 revealed that HA-Rsu-1 transfectant cell lines expressed elevated levels of p21CIP CDK inhibitor. Perturbations in signal transduction pathways which can be activated by Ras were detected in the Ha-Rsu-1 transfectants. Exposure of serum-starved cells to EGF revealed that expression of HA-Rsu-1 increased ERK-2 kinase activation, decreased activation of Jun kinase and inhibited Rho-dependent Rho-alpha kinase (ROK) activity compared to control cells. While serum starvation reduced AKT activity to undetectable levels in HA-Rsu-1 transfectants but not in control MCF7 cells, activation of AKT kinase by serum was unaffected by HA-Rsu-1 expression. Finally, the level of c-myc transcription in HA-Rsu-1 transfectants reached only 60% of the MCF7 control cell line following serum stimulation of starved cells while Fos RNA levels were similar to control cells. These results demonstrate that increased Rsu-1 expression critically altered cell cycle regulation and growth of MCF7 cells as well as signaling pathways in MCF7 cells required for malignant growth.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Akasaka K, Tamada M, Wang F, Kariya K, Shima F, Kikuchi A, Yamamoto M, Shirouzu M, Yokoyama S, Katoaka T: Differential structural requirements for interaction of Ras protein with its distinct downstream effectors. J Biol Chem 271: 5353–5359, 1996

    PubMed  Google Scholar 

  2. Albini A, Graf J, Kitten G, Kleinman H, Martin G, Veillette A, Lippman M: 17-beta-estradiol regulates and v-Ha-Ras transfection constitutively enhances MCF7 breast cancer cell interactions with the plasma membrane. Proc Natl Acad Sci 83: 8182–8186, 1986

    PubMed  Google Scholar 

  3. Bacus, S, Yarden Y, Oren M, Chin DM, Lyass L, Zelnick CR, Kazarov A, Toyofuku W, Gray-Bablin J, Beerli RR, Hynes NE, Nikoforov M, Haffner R, Gudkov A, Keyomarsi K: Neu differentiation factor (Heregulin) activates a p53-dependent pathway in cancer cells. Oncogene 12: 2535–2547, 1996

    PubMed  Google Scholar 

  4. Basolo F, Elliott J, Tait L, Chen XQ, Maloney T, Russo J, Pauley R, Momiki S, Caamano J, Klein-Szanto AJP, Koszaika M: Transformation of human breast epithelial cells by c-Ha-Ras oncogene. Mol Carcino 4: 25–35, 1991

    Google Scholar 

  5. Ben-Levy R, Paterson H, Marshall C, Yarden Y: A single autophosphorylation site confers oncogenicity to the Neu/ErbB-2 receptor and enables coupling to the MAP kinase pathway. EMBO J 13: 3302–3311, 1994

    PubMed  Google Scholar 

  6. Blagosklonney M, Prabhu N, El-Diery W: Defects in p21WAF-1/CIP-1, Rb, and c-myc signaling in phorbol ester-resistant cancer cells. Cancer Res 57: 320–325, 1997

    PubMed  Google Scholar 

  7. Bunday L, Downward J: EGF regulates p21Ras through the formation of a complex of receptor, Grb2 adaptor protein, and SOS nucleotide exchange factor. Cell 73: 611–620, 1993

    PubMed  Google Scholar 

  8. Chardin P, Camonis J, Gale N, VanAelst L, Schlessinger J, Wigler M, Bar-Sagi D: Human Sos1:a guanine nucleotide exchange factor for Ras that binds to Grb2. Science 260: 1338–1343, 1993

    PubMed  Google Scholar 

  9. Choi Y, Zhang L, Lee W, Park K: Genistein-induced G2/M arrest is associated with the inhibition of cyclin B1 and the induction of p21 in human breast carcinoma cells. Int J Oncol 13: 391–396, 1998

    PubMed  Google Scholar 

  10. Clark G, Der C: Aberrant function of the Ras signal transduction pathway in human breast cancer. Breast Cancer Res Treat 35: 133–144, 1995

    PubMed  Google Scholar 

  11. Clark G, Westwick J, Der C: p120 GAP modulates Ras activation of the Jun kinases and transformation. J Biol Chem 272: 1677–1681, 1996

    Google Scholar 

  12. Clark J, Santos-Moore A, Stevenson L, Frackelton A: Effects of tyrosine kinase inhibitors on the proliferation of human breast cancer cell lines and proteins important in the Ras signaling pathway. Int J Cancer 65: 186–191, 1996

    PubMed  Google Scholar 

  13. Coso O, Chiariello M, Yu J-C, Teramoto H, Crespo P, Xu N, Miki T, Gutkind JS: The small GTP-binding proteins Rac1 and CDC42Hs regulate the activity of the JNK/SAPK Signaling pathway. Cell 81: 1137–1146, 1995

    PubMed  Google Scholar 

  14. Cutler M, Bassin R, Zanoni L, Talbot N: Isolation of rsp-1, a Novel cDNA capable of suppressing v-ras. Mol Cell Biol 12: 3750–3756, 1992

    PubMed  Google Scholar 

  15. Draetta G: Mammalian G1 cyclins. Current Opin Cell Biol 6: 842–846, 1994

    Google Scholar 

  16. Facchini L, Penn L: The molecular role of myc in growth and transformation: recent discoveries lead to new insights. Faseb J 12: 633–651, 1998

    PubMed  Google Scholar 

  17. Franke T, Kaplan D, Cantley L. Downstream AKTion blocks apoptosis. Cell 88: 435–437, 1997

    PubMed  Google Scholar 

  18. Gorospe M, Shack S, Guyton K, Samid D, Holbrook N: Upregulation and functional role of p21 WAF=CIP during growth arrest of human breast carcinoma cell lines by phenyacetate. Cell Growth Differ 7: 1609–1615, 1996

    PubMed  Google Scholar 

  19. Hill C, Wynne J, Treisman R: The Rho family GTPases RhoA, Rac1, and CDC42Hs regulate transcriptional activation by SRF. Cell 81: 1159–1170, 1995

    PubMed  Google Scholar 

  20. Janes P, Daly R, DeFazio A, Sutherland R: Activation of the Ras signaling pathway in human breast cancer cells overexpressing erbB-2. Oncogene 9: 3601–3608, 1994

    PubMed  Google Scholar 

  21. Jones J, Cui X-S, Medina D, Donehower L: Heterozygosity of p21WAF/CIP1 enhances tumor cell proliferation and cyclin Dassociated kinase activity in a murine mammary cancer model. Cell Growth Differ 10: 213–221, 1999

    PubMed  Google Scholar 

  22. Khosravi-Far R, Solski P, Clark G, Kinch M, Der C: Activation of Rac1, RhoA, and mitogen activated protein kinases is required for Ras tranformation. Mol Cell Biol 15: 6443–6453, 1995

    PubMed  Google Scholar 

  23. Khosravi-Far R, White M, Westwick J, Solski P, Chrzanowska-Wodnicka M, VanAelst L, Wigler M, Der C: Oncogenic Ras activation of Raf/mitogen-activated protein kinase-independent pathways is sufficient to cause tumorigenic transformation. Mol Cell Biol 16: 3923–3933, 1996

    PubMed  Google Scholar 

  24. LaBaer J, Garrett M, Stevenson L, Slingerland J, Sandhu C, Chou H, Fattaey A, Harlow E: New functional activities for the p21 family of CDK inhibitors. Genes Develop 11: 847–862, 1997

    PubMed  Google Scholar 

  25. Lebowitz P, Davide J, Prendergast G: Evidence that farnesyltransferase inhibitors suppress Ras transformation by interfering with Rho activity. Mol Cell Biol 15: 6613–6622, 1995

    PubMed  Google Scholar 

  26. Leung T, et al.: A novel serine/threonine kinase binding the Ras-related RhoA GTPase which translocates the kinase to peripheral membranes. J Biol Chem 270: 29051–29054, 1995

    PubMed  Google Scholar 

  27. Levi A, Eldridge J, Paterson B: Molecular cloning of a gene sequence regulated by nerve growth factor. Science 238: 393–397, 1985

    Google Scholar 

  28. Lowenstein EJ, Daly RJ, Batzer AG, Li W, Margolis B, Lammers R, Ulrich A, Skolnik EY, Bar-Sagi D, Schlessinger J: The SH2 and SH3 domain-containing protein GRB2 links receptor tyrosine kinases to ras signaling. Cell 70: 413–442, 1992

    Google Scholar 

  29. Marcu K, Bossone S: Myc function and regulation. Ann Rev Biochem 61: 809–860, 1992

    PubMed  Google Scholar 

  30. Masuelli L, Cutler M: Increased expression of the Ras suppressor, Rsu-1, enhances Erk-2 activation and ihnibits Jun kinase activation. Mol Cell Biol 16: 5466–5476, 1996

    PubMed  Google Scholar 

  31. Masuelli L, Ettenberg S, Vasaturo F, Vestergaard-Sykes K, Cutler M: The Ras suppressor, Rsu-1, enhances NGF-induced differentiation of PC12 cells by induction of p21CIP. Cell Growth Differ 10: 555–564, 1999

    PubMed  Google Scholar 

  32. Minden A, Lin A, Claret F-X, Abo A, Karin M: Selective activation of the JNK signaling cascade and c-Jun transcriptional activity by the small GTPases Rac and Rho. Cell 81: 1147–1157, 1995

    PubMed  Google Scholar 

  33. Mitchell K, El-Deiry W: Overexpression of c-myc inhibits p21WAF-1/CIP-1 expression and induces S-phase entry in TPA-sensitive human cancer cells. Cell Growth Differ 10: 223–230, 1999

    PubMed  Google Scholar 

  34. Oldham S, Clark G, Gangarosa L, Coffey R Jr, Der C: Activation of the Raf-1/MAP kinase cascade is not sufficient for Ras transformation of RIE-1 epithelial cells. Proc Natl Acad Sci 93: 6924–6928, 1996

    PubMed  Google Scholar 

  35. Olson M, Ashworth A, Hall A: An essential role for Rho, Rac, and cdc42 GTPases in cell cycle progression through G1. Science 269: 1270–1272, 1995

    PubMed  Google Scholar 

  36. Olson M, Peterson H, Marshall C: Signals from Ras and Rho GTPases interact to regulate expression of p21 WAF=CIP. Nature 394: 295–299, 1998

    PubMed  Google Scholar 

  37. Prendergast G, Khosravi-Far R, Solski P, Kurzawa H, Lebowitz P, Der C: Critical role of Rho in cell transformation by oncogenic Ras. Oncogene 10: 2289–2296, 1995

    PubMed  Google Scholar 

  38. Qui RG, Chen J, Kirn D, McCormick F, Symons M: An essential role for Rac in Ras transformation. Nature 374: 457–459, 1995

    PubMed  Google Scholar 

  39. Rosfjord E, Maemura M, Johnson M, Torri J, Akiyama S, Woods V, Dickson R: Activation of protein kinase C by phorbal esters modulates a2b1 integrin onMCF7 breast cancer cells. Exp Cell Res 248: 260–271, 1999

    PubMed  Google Scholar 

  40. Steeg P, Zhou Q: Cyclins and breast cancer. Breast Cancer Res Treat 52: 17–28, 1998

    PubMed  Google Scholar 

  41. Sukamar S, Carney W, Barbacid M: Independent molecular pathways in initiation and loss of hormone responsiveness in breast carcinomas. Science 240: 524–526, 1988

    PubMed  Google Scholar 

  42. Weaver V, Peterson O, Wang F, Larabell C, Briand P, Damsky C, Bissell M: Reversion of the malignant phenotype of human breast cells in three-dimensional culture and in vivo by integrin-bloocking antibodies. J Cell Biol 137: 231–245, 1997

    PubMed  Google Scholar 

  43. White M, Nicollette C, Minden A, Polverino A, VanAelst L, Karin M, Wigler M: Multiple Ras functions can contribute to mammalian cell transformation. Cell 80: 533–541, 1995

    PubMed  Google Scholar 

  44. Yu D, Jing T, Liu B, Yao J, Tan M, McDonnell T, Hung M: Overexpression of ErbB2 blocks Taxol-induced apoptosis by upregulation of p21CIP which inhibits p34cdc2 kinase. Mol Cell 2: 581–591, 1998

    PubMed  Google Scholar 

  45. Zi X, Feyes D, Agarwal R: Anticarcinogenic effect of the favonoid anti-oxidant, sillymarin, in human breast cancer cells MDA-MB468: induction of G1 arrest through an increase in CIP1/p21 concommitant with a decrease in kinase activity of cyclin dependent kinases and associated cyclins. Clin Cancer Res 4: 1055–1064, 1998

    PubMed  Google Scholar 

Download references

Authors
  1. F. Vasaturo
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. G.W. Dougherty
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. M.L. Cutler
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Vasaturo, F., Dougherty, G. & Cutler, M. Ectopic expression of Rsu-1 results in elevation of p21CIP and inhibits anchorage-independent growth of MCF7 breast cancer cells. Breast Cancer Res Treat 61, 69–78 (2000). https://doi.org/10.1023/A:1006462323260

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1006462323260

Search

Navigation